| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |